Intrinsic Value of S&P & Nasdaq Contact Us

HEXO Corp. HEXO NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
19/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

HEXO Corp. (HEXO) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 18/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
19/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
MOAT
8/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — HEXO

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-38.68
Book Value / Share$0.00
Revenue / Share$6.88
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2014 $0.00 $0.00 $-29.29K -
2015 $-0.92 $0.00 $-29.29K -
2016 $0.00 $0.00 $0.00 -
2017 $-11.88 $4.1M $-12.42M -303.1%
2018 $-9.75 $4.93M $-23.35M -473.2%
2019 $-21.47 $47.54M $-81.56M -171.6%
2020 $-63.43 $80.78M $-546.49M -676.5%
2021 $-12.62 $123.77M $-114.76M -92.7%
2022 $-38.68 $191.1M $-1.07B -561.8%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message